Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.3200
+0.0140 (4.58%)
At close: Jun 27, 2025, 4:00 PM
0.3240
+0.0040 (1.25%)
After-hours: Jun 27, 2025, 7:55 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $8.02 million as of June 27, 2025. Its market cap has decreased by -88.23% in one year.
Market Cap
8.02M
Enterprise Value
7.23M
1-Year Change
-88.23%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $8.02M, a decrease of -87.85%. That is a compound annual growth rate of -65.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 8.02M | -69.82% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.51B |
| Johnson & Johnson | 366.18B |
| AbbVie | 327.76B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 277.24B |
| Abbott Laboratories | 240.24B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |